Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?
Author:
Affiliation:
1. Cellcure Center, Gatot Soebroto Central Army Hospital, Jakarta, Indonesia
Funder
Cellcure Center RSPAD Gatot Soebroto
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,Molecular Medicine,Immunology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2080658
Reference108 articles.
1. A Novel Coronavirus from Patients with Pneumonia in China, 2019
2. Herd Immunity: Understanding COVID-19
3. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
4. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
5. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus;Vaccines;2024-08-27
2. Recent Advances in Immune Regulation by Targeting Dendritic Cells using Small Interfering RNAs;Current Molecular Medicine;2024-06-07
3. Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa;Vaccines;2024-04-12
4. A generalizable and easy-to-use COVID-19 stratification model for the next pandemic via immune-phenotyping and machine learning;Frontiers in Immunology;2024-03-27
5. Focusing on the cytokine storm in the battle against COVID-19: the rising role of mesenchymal-derived stem cells;Stem Cells;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3